ADVM NASDAQ
Adverum Biotechnologies, Inc.
1W: +4.8%
1M: +0.9%
3M: +31.7%
1Y: -23.4%
3Y: -33.9%
5Y: -96.9%
$4.36
Last traded 2025-12-09 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
📊 Key Metrics
TTM$0M
Revenue
-100.0% YoY
$-204M
Net Income
-88.4% YoY
$-138M
Free Cash Flow
-60.7% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-462.1%
ROA-133.3%
ROIC-2266.2%
Valuation
P/E-0.7
P/B-1.8
EV/EBITDA-0.8
Leverage
Debt/Equity-1.60
Current Ratio0.65
Interest Cov.0.0x
Quality Scores
Piotroski F1/9
Altman Z-32.66
Beneish M0.00